High levels of Cyr61 correlated with relapse in TNBC patients, and silencing of Cyr61 reduced the invasiveness of TNBC cell lines and reduced tumor burden and microvascular density in xenograft mouse TNBC tumors [65]. This evidence concerns the gene CCN1 and neoplasm.